HealthCare Innovation and the Konrad-Adenauer-Stiftung signed a partnership in June 2026. It covers four strategic dialogues and one in-depth study, under the title Co-Creating a Resilient and Integrated Health Ecosystem in Tunisia. The first dialogue, reported on 25 June 2026, addressed digital tools and AI for a One Health approach.

HealthCare Innovation is the HealthTech cluster based in Monastir, Tunisia. The Konrad-Adenauer-Stiftung is a German political foundation with an office in Tunis.

What the two organisations agreed to do

The partnership has a narrow object. HCI and KAS co-organise strategic dialogues and produce studies. One question runs through them. How do health, technology and innovation work together to drive economic growth?

The method counts as much as the subject. Each dialogue puts public bodies, firms, academics and innovators in one room. Each one produces a written output. Four dialogues and one study in all.

That format answers a gap. Tunisia has no standing forum on this subject. A ministry official, a hospital director, a startup founder and a researcher rarely read the same file at the same time.

The first dialogue: One Health, digital tools and AI

The opening dialogue took the title Digital Tools and AI to Support an Inclusive and Multi-Stakeholder One Health Approach.

Participants worked on four functions, not on technology in general. Prevention, surveillance, early detection, and response to complex health threats. For each one they asked the same question. What do digital tools, AI, data and cross-sector work actually add?

The room held public bodies, firms, academics, innovators and healthcare leaders. HCI named several of them. Dr Faten Khemaissia, Mohamed Azaouzi, Wissem Bahrouni, Nour Souabni, Kaouther Boussema, Imen Nefzi, Chihebeddine Romdhani, Asma Saidouni, Alla El-Awaisi, Sarra Ben Ayed and Fatma Tritar. Michael Bauer represented the Konrad-Adenauer-Stiftung.

« One Health cannot be delivered by the health sector alone. Our role as a cluster is to put veterinary services, environmental agencies, clinicians and technology teams around one table, and to make sure something is written down at the end. » Dr Haroun Ouanes, Director, HealthCare Innovation

Why One Health, and why now

One Health treats human, animal, plant and environmental health as one system. The idea is not Tunisian. Four international bodies published a joint plan of action on it in 2022  . They are the Food and Agriculture Organization, the United Nations Environment Programme, the World Health Organization and the World Organisation for Animal Health.

The plan runs on six action tracks.

The timing matters. On 14 August 2026 the four bodies extended the plan to 2029  . A country that builds capacity now builds it against a frame that will still hold in three years.

What is at stake for Tunisia

Two pressures meet here. Noncommunicable diseases cause around 86 percent of deaths in Tunisia . Those need long follow-up and shared data. Zoonotic and vector-borne risks need watch across veterinary, environmental and human health services. Those services rarely share systems.

Both problems share a root. The data exists but sits in separate hands. That is a question of interoperability before it is one of technology. We treat it on its own in FHIR, Sahetna.tn and the interoperability gap .

HCI holds a clear position. Put together, One Health, digital workflows, innovation and multi-actor work form a strategic lever. The aim is a Tunisian model that is resilient, scalable and open to the world.

What comes next

Three dialogues and the study remain. The second one moved the subject inside the company, and we cover it in AI and workplace well-being 

Bodies and firms that want to join a later session can reach the cluster through the Community page . Those looking for support on health data governance can start with our Services  .

Frequently Asked Questions

Q: What is the HCI and KAS project?

A: A partnership signed in June 2026. It covers four strategic dialogues and one in-depth study, under the title Co-Creating a Resilient and Integrated Health Ecosystem in Tunisia. It looks at health, technology and innovation as a driver of economic growth.

Q: What was the first dialogue about?

A: Digital tools and artificial intelligence supporting an inclusive and multi-stakeholder One Health approach, applied to prevention, surveillance, early detection and response.

Q: What does One Health mean?

A: It treats human, animal, plant and environmental health as one system. Four international bodies, FAO, UNEP, WHO and WOAH, run a joint plan of action on it. They extended it in August 2026 to run until 2029.

Q: Who took part?

A: Public institutions, private sector actors, academics, innovators and healthcare leaders. Michael Bauer represented the Konrad-Adenauer-Stiftung.

Q: How many dialogues remain?

A: Three, plus the study. The second one, on AI and workplace well-being, was reported in July 2026.

HCI Resources

Accelerating Innovation in HealthTech 

Startup Programs 

Pharma & Medical Device Regulatory Services 

Experts Network 

Community Overview 

External Citations

World Health Organization, FAO, UNEP, WOAH – One Health Joint Plan of Action 2022-2026 

World Health Organization – Quadripartite extends the One Health Joint Plan of Action to 2029 (2026) 

World Health Organization – Tunisia country data 

Konrad-Adenauer-Stiftung – Tunisia office 

L’article HCI and Konrad-Adenauer-Stiftung Open a National Dialogue on One Health in Tunisia est apparu en premier sur HealthCare Innovation.

HealthCare Innovation joined Euromed Days 2026 in Nicosia from 15 to 17 June. The meeting gathered more than 120 delegates from 26 Euro-Mediterranean countries. ANIMA Investment Network and Invest Cyprus co-organised it. Dr Haroun Ouanes and Hatem Fathallah represented the cluster.

HealthCare Innovation is the HealthTech cluster based in Monastir, Tunisia. Euromed Days brings together development agencies, clusters and investors from across the region.

Why a Tunisian health cluster travels to Cyprus

Health innovation crosses borders faster than health funding does. A tool built in Tunis can serve a hospital in Nicosia. The money to build it rarely moves the same way.

Euromed Days puts cluster managers, agencies and investors in one room for three days. For a cluster, that room is the product. A meeting held there can become a joint project two years later.

The link to E-HealthNAx

ANIMA Investment Network  . That is the European programme funding our E-HealthNAx project with France and Poland.

The numbers behind it are public. The European Union covers up to 90 percent of a 7.8 million euro budget. The programme runs until 2026 across seven southern Mediterranean countries, where 81 clusters have been identified.

That link shortened several conversations in Nicosia. A cluster already delivering under the programme does not have to explain what it is. We describe that delivery in E-HealthNAx 2026 launch day in Tunis

« We do not go to these meetings to present Tunisia. We go to find the two or three partners who have the same problem we do, and who will still answer the phone in eighteen months. » Dr Haroun Ouanes, Director, HealthCare Innovation

The funding gap behind the travel

There is a hard reason a cluster invests three days in a room in Cyprus.

African healthtech startups raised 215 million dollars in 2025, up 232 percent on the year before, according to a sector report on digital health funding in Africa. Tunisian healthtech companies have raised around 2.24 million dollars in total, according to the Tracxn database as of May 2026. Both figures come from commercial trackers rather than official statistics, and both should be read as orders of magnitude.

Even read loosely, the gap is not a talent gap. We examine its real causes in 68 startups, 2.24 million dollars 

Regional access is often what separates a pilot from a company. A small national market rarely supports a healthtech firm alone.

Why the standards conversation matters here

Cooperation is not only about money. The Global strategy on digital health of the World Health Organization laces governance and interoperability among the pillars of safe digital health systems.

Neither pillar stops at a border. A Tunisian medical device that meets one standard in Tunis and another in Nicosia serves no one. That is why interoperability sits on the same agenda as investment, and we treat it in FHIR, Sahetna.tn and the interoperability gap 

What comes next

HCI will follow up on the contacts made in Nicosia. Cluster agreements and investor introductions are the two tracks.

Firms preparing a European market entry can start with the regulatory groundwork. See our Pharma and medical device services . Clusters looking for a Tunisian counterpart can reach us through the Clusters and incubators page 

Frequently Asked Questions

• Q: What is Euromed Days?

A: An annual meeting of economic development agencies, clusters and investors from the Euro-Mediterranean region, organised by ANIMA Investment Network with a national host. The 2026 edition took place in Nicosia, Cyprus.

• Q: When did the 2026 edition take place?

A: From 15 to 17 June 2026, with more than 120 delegates from 26 countries.

• Q: Who represented HealthCare Innovation?

A: Dr Haroun Ouanes and Hatem Fathallah.

• Q: How does this connect to E-HealthNAx?

A: ANIMA Investment Network steers Euromed Clusters Forward, the European programme funding E-HealthNAx. The same network supports both.

• Q: Can a Tunisian startup join these meetings?

A: Cluster members can be introduced through HealthCare Innovation. Contact the cluster to be considered for the next edition.

HCI Resources

Accelerating Innovation in HealthTech 

Startup Programs 

Pharma & Medical Device Regulatory Services 

Experts Network 

Community Overview 

External Citations

ANIMA Investment Network – Euromed Days 2026 

ANIMA Investment Network – Euromed Clusters Forward 

World Health Organization – Global strategy on digital health 2020-2025 

L’article HealthCare Innovation at Euromed Days 2026 in Nicosia est apparu en premier sur HealthCare Innovation.

Pharma 4 Novation launched on 1 February 2025. It is Tunisia’s first pre-incubation programme for pharmacists and pharmacy students. Four organisations built it together, and the first cohort engaged more than 15 projects. The second annual prize closed its applications on 5 April 2026.

HealthCare Innovation is the HealthTech cluster based in Monastir, Tunisia. This article looks at the alliance behind the programme rather than at the programme calendar.

The gap the programme was built for

Three gaps shaped the design. Tunisian pharmacy training carries little innovation content. Routes from an idea to a company are thin. Market access is fragmented.

A pharmacist who has an idea therefore has nowhere to take it. The idea does not fail on merit. It fails on the absence of a next step.

Four partners, four things none of the others could bring

The alliance is the interesting part. Each partner supplies one thing the others cannot.

Attijari bank runs the funding sessions.

Look at the second column again. Remove any one line and the programme stops working. Without the faculty there is no room and no cohort. Without the professional council the profession does not recognise the certificate. Without the manufacturer the students invent problems instead of solving real ones. Without the bank the funding session is theory.

« We did not start by writing a programme. We started by asking who owns each thing a young pharmacist needs, then went to see them one by one. The design followed. » Dr Haroun Ouanes, Director, HealthCare Innovation

What the cohort actually goes through

The pathway has four stages: idea validation, business modelling, regulatory readiness, market access.

Training covers business design thinking and market studies. Webinars run from France and Tunisia. Rapid prototyping workshops address AI and software. Funding sessions run with the bank. Mentoring gives access to hospital and laboratory validation networks.

The first edition engaged more than 15 projects. They spanned AI-assisted diagnosis, emerging biotech solutions, and digital tools for pharmaceutical care.

Second edition, and the shift to a prize

The 2026 edition added a competitive layer. The second annual prize closed applications on 5 April 2026. The winning project receives 1,000 dinars. Four criteria decide: innovation, impact, maturity, feasibility.

The final pitch took place on 11 April 2026 at the Hilton Skanes in Monastir, during the 24th Pharmaceutical Days of the Centre. HCI and the programme team ran an Innovation Galaxy at the same venue. Dr Haroun Ouanes, Said Naija and Nermine Dammak led the sequence.

Placing the final inside a professional congress is deliberate. The winner pitches to pharmacists, not to a jury of programme staff. We use the same method across specialties, described in the Innovation Galaxy at the Mediterranean Geriatrics Forum

What is replicable, and what is not

Three lessons carry to other health professions.

• Start from ownership, not from content. The programme works because four owners each keep their part. A single organisation running all four roles would produce a weaker version.
• An industrial partner changes the exercise. Real problems come from a company with a real constraint. We examine that mechanism on its own in Open innovation in pharma 
• A pre-incubator produces trained people more reliably than it produces companies. That is a fair result, provided the programme says so.

One limit is worth stating. Noncommunicable diseases cause around 86 percent of deaths in Tunisia  . Those patients see a community pharmacist more often than a physician. The International Pharmaceutical Federation  pushes the profession towards prevention and follow-up on exactly that ground. A pre-incubation programme reaches a few dozen pharmacists a year. Changing what the profession does at scale needs a different instrument.

Faculties and professional bodies that want to build a similar alliance can reach us through the Projects page. Pharmacists with a project can start with our Startup programmes 

Frequently Asked Questions

Q: What is this programme?

A: Pharma 4 Novation, Tunisia’s first pre-incubation scheme for pharmacists and pharmacy students, launched on 1 February 2025.

Q: Who created it?

A: HealthCare Innovation, the Faculty of Pharmacy of Monastir, the Regional Council of Pharmacists and Opalia Recordati. Attijari bank runs the funding sessions.

Q: What does a participant go through?

A: Four stages. Idea validation, business modelling, regulatory readiness, market access. Training, webinars, prototyping workshops, funding sessions and mentoring support each stage.

Q: How many projects took part in the first edition?

A: More than 15, across AI-assisted diagnosis, biotech and digital pharmaceutical care tools.

Q: What is the annual prize?

A: A competition attached to the programme. The second edition closed applications on 5 April 2026, with a prize of 1,000 dinars and a final pitch on 11 April 2026 in Monastir.

HCI Resources

Accelerating Innovation in HealthTech 

Startup Programs 

Pharma & Medical Device Regulatory Services 

Experts Network 

Community Overview 

Pharma 4 Novation project page

External Citations

International Pharmaceutical Federation – global pharmacy body 

World Health Organization – Tunisia country data 

Opalia Recordati – industry partner 

Regional Council of Pharmacists of Tunisia 

L’article Pharma 4 Novation, Eighteen Months On: What a Four-Way Alliance Taught Us est apparu en premier sur HealthCare Innovation.

Four French HealthTech startups spent the morning of 26 March 2026 with clinicians and researchers in Monastir. The session ran from 09:00 to 12:30 at the Faculty of Medicine. It formed the academic leg of E-HealthNAx, the Euro-Mediterranean programme run by HealthCare Innovation.

HealthCare Innovation is the HealthTech cluster based in Monastir, Tunisia. The startups came through BioValley France, the health innovation cluster based in Strasbourg.

Where this day sits in the wider mission

E-HealthNAx ran from 24 to 28 March 2026 across Tunis and Monastir. The Tunis leg opened the week with an institutional session and more than 100 business meetings. We cover it in E-HealthNAx 2026 launch day in Tunis .

Monastir did something different. Tunis put companies in front of buyers. Monastir put them in front of clinicians and researchers, which is a harder audience and a more useful one.

HealthCare Innovation runs the programme with BioValley France and MedSilesia Cluster. The Faculty of Medicine of Monastir and Smart Lab FMM hosted the day. The European Union funds it through Euromed Clusters Forward . ANIMA Investment Network, Berytech, Business France and Proovlab take part.

What the morning covered

The programme had four parts. Startup presentations. A discussion on artificial intelligence and the French HealthTech ecosystem. Meetings with healthcare professionals and researchers. Networking around the stands.

HCI named several participants. Sandra Chalhoub, Carine Remetter, Mohamed Ibn Alkadi, Rania Jebri, Damien Forest, Aleksandra Szczerbak-Ruta, Noemie Jordy, Aziz Frikha, Mohamed Azaouzi, Sana Boujaafar and Charfeddine Amri. InSimo  also took part. It builds surgical simulation software.

One detail is worth recording. The announcement of 12 March mentioned five French startups. The reports published on 2 and 7 April mention four. No source explains the difference. We keep the figure from the reports.

« A clinician will find the gap in your product in ten minutes. That is worth more to a startup than a month of market research, and it is the reason we hold one leg of every mission inside a faculty. » Dr Haroun Ouanes, Director, HealthCare Innovation

Why a clinician audience changes the product

A startup that pitches to investors is selling a story. A startup that pitches to a practising physician is defending a workflow. The questions differ, and so do the answers a founder walks away with.

The difference has a regulatory side too. The Global strategy on digital health of the World Health Organization names governance, interoperability and workforce skills as pillars of safe digital health systems. None of the three can be tested in a demo room.

Proof requirements move the same way. The NICE framework on evidence standards for digital health grades the proof required against the risk a tool carries. In the United States, the FDA issued a final guidance on 18 December 2025 on real-world data for medical devices  . It replaces the 2017 text and now allows aggregated, de-identified data.

Read together, those two moves say something practical. Data collected in real settings counts. A Tunisian hospital that tests a French tool is producing evidence, not just giving feedback.

What the visitors took home

Three things came out of the morning for the European side.

• A care pathway in Tunisia does not match the French one. Volumes, referral habits and payment routes differ. A product built for one has to be reworked for the other.
• Regulatory status travels badly. A CE mark opens a conversation in Tunis, it does not close one. We set out what applies locally in Software as a Medical Device: Tunisia’s regulatory blind spot 
• Faculties are entry points. A researcher who tests a tool becomes its first local reference. In a market where distributors rely on clinical reputation, that counts.

Firms preparing a North African entry can start with our Pharma and medical device services . Faculties and research teams that want to host a session can reach us through the Community page .

Frequently Asked Questions

Q: When and where did the Digital Health Innovation Day take place?

A: On Thursday 26 March 2026, from 09:00 to 12:30, in the ceremonial auditorium of the Faculty of Medicine of Monastir.

Q: How many French startups attended?

A: Four, according to the reports published in April 2026. The announcement of 12 March had mentioned five. No source explains the difference.

Q: Which programme was this part of?

A: E-HealthNAx. HealthCare Innovation runs it with BioValley France and MedSilesia Cluster. The European Union funds it under Euromed Clusters Forward.

Q: Who hosted the day?

A: The Faculty of Medicine of Monastir and Smart Lab FMM.

Q: How can a French or Polish company join a future mission?

A: Through its national cluster, or by contacting HealthCare Innovation directly.

HCI Resources

Accelerating Innovation in HealthTech 

Startup Programs 

Pharma & Medical Device Regulatory Services 

Experts Network 

Community Overview 

External Citations

World Health Organization – Global strategy on digital health 2020-2025 

National Institute for Health and Care Excellence – Evidence standards framework for digital health technologies 

Federal Register – Use of Real-World Evidence To Support Regulatory Decision-Making for Medical Devices (2025) 

ANIMA Investment Network – Euromed Clusters Forward 

L’article Digital Health Innovation Day: French Startups Meet Clinicians in Monastir est apparu en premier sur HealthCare Innovation.

E-HealthNAx opened in Tunis on 25 March 2026. HealthCare Innovation gathered more than 80 participants and a delegation of 14 French and Polish HealthTech companies. Over 100 matchmaking meetings took place during the five-day mission, which ran from 24 to 28 March across Tunis and Monastir.

HealthCare Innovation is the HealthTech cluster based in Monastir, Tunisia. E-HealthNAx links the Tunisian digital health ecosystem with its French and Polish counterparts. It also gives European medical technology firms a first structured route into North Africa.

Who funds E-HealthNAx and who runs it

Three clusters implement the programme. HealthCare Innovation leads in Tunisia, BioValley France  in France, and MedSilesia leads in Poland. Proovlab , Business France and the CQE project of GIZ Tunisia  support the delivery.

The European Union funds the programme through Euromed Clusters Forward  . ANIMA Investment Network leads it with Berytech  . The programme runs until 2026 on a budget of 7.8 million euros. The European Union covers up to 90 percent of it. It reaches 81 clusters in seven southern Mediterranean countries.

A second channel supports the export side. The action belongs to EXPORTI, under the PACE-AMIT programme of the CQE project. GIZ Tunisia delivers it with the Tunisian Ministry of Industry, Mines and Energy. The European Union in Tunisia and the German ministry for economic cooperation, known as BMZ, fund it.

Which companies came, and from where

Five Polish medical technology firms travelled to Tunis. They were Accrea Medical Robotics, Meden-Inmed  , Orthoget  , Technomex and Zarys  . MedSilesia coordinated the group. It worked with the Upper Silesian Accelerator, known as GAPR .

The French group came through BioValley France, the health cluster based in Strasbourg. It included InSimo  , which builds surgical simulation software, and Praxy.ai .

On the Tunisian side, the room held health authorities, public bodies, non-governmental organisations, drug and device makers, digital health startups and sector experts.

What the Polish embassy said

Agata Wadowska, Chargee d’affaires a.i. of the Embassy of Poland in Tunis , opened the session. She set out how economic diplomacy supports Polish firms abroad. New technologies, biotechnology included, are a stated priority of the Polish government and of European institutions.

She then placed the two countries side by side. Poland ranks sixth in the Digital Decade eHealth Indicator Study 2025. That puts it among the most advanced European countries in health system digitisation. Tunisia holds a similar position in its own region. The embassy said it expects this first meeting to produce lasting partnerships.

That framing matters for a Tunisian cluster. It positions the country as a peer rather than a destination market.

What the day produced

The day ran in four blocks. An institutional session opened it. Then came an exchange on digital health priorities in Tunisia, expert talks, and pitches from the European firms. B2B meetings filled the rest of the day.

More than 100 matchmaking meetings were held. The mission then moved to Monastir on 26 March. French startups spent a day there with clinicians and researchers at the Faculty of Medicine. We cover that day in Digital Health Innovation Day in Monastir

For the European firms, the week worked as a soft landing. They met distributors, clinicians, regulators and possible partners in five days. That first step usually takes a year.

What we take from it

Dr Haroun Ouanes, Director of HealthCare Innovation, summed up the outcome. “E-HealthNAx confirms Tunisia’s ability to connect European innovation with the real needs of the Tunisian and North African markets, and to open new horizons for collaboration.”

Three conclusions stand out.

• Regulatory readiness decides who converts. Firms who arrived with a compliance file moved faster than firms who arrived with a demo alone. We set out what that file requires in Software as a Medical Device: Tunisia’s regulatory blind spot 
• Traffic runs both ways. Two weeks earlier, four Tunisian startups took Tunisian innovation to Paris. WejdenSpire, ProovLab, NormSafety and MedGalaxis attended the MedInTechs congress on 9, 10 and 11 March 2026.
• Embassies open doors a cluster cannot open alone. The Polish group came through a channel built by the embassy and an accelerator.

HealthCare Innovation will use the same route for the next groups. Firms preparing a North African market entry can start with our Clusters and incubators services 

Frequently Asked Questions

Q: What is E-HealthNAx?

A: E-HealthNAx is a Euro-Mediterranean programme. It links digital health and medical technology ecosystems in Tunisia, France and Poland. HealthCare Innovation, BioValley France and MedSilesia run it. The European Union funds it under Euromed Clusters Forward.

Q: When and where did the 2026 mission take place?

A: The mission ran from 24 to 28 March 2026 in Tunis and Monastir. The official launch day was held in Tunis on 25 March 2026.

Q: Which European companies took part?

A: Fourteen startups and firms from France and Poland joined the group. Five Polish makers are named in the press: Accrea Medical Robotics, Meden-Inmed, Orthoget, Technomex and Zarys. InSimo and Praxy.ai took part on the French side.

Q: How many business meetings were held?

A: More than 100 matchmaking meetings were facilitated during the mission.

Q: How can a company join the next edition?

A: European firms apply through their national cluster. Tunisian firms can contact HealthCare Innovation through the services page.

HCI Resources

Accelerating Innovation in HealthTech 

Startup Programs 

Pharma & Medical Device Regulatory Services 

Experts Network 

Community Overview 

Projects 

External Citations

La Presse de Tunisie – E-HealthNAx 2026 : la Tunisie confirme son role de passerelle pour la sante digitale euro-mediterraneenne (2026) 

Managers – Cinq entreprises polonaises prospectent le marche tunisien de la healthtech (2026) 

Entreprises Magazine – MedTech : la Pologne et la France lorgnent la Tunisie (2026) 

ANIMA Investment Network – Euromed Clusters Forward 

Berytech – Euromed Clusters Forward programme page 

L’article HealthCare Innovation Opens E-HealthNAx With 14 European HealthTech Startups in Tunis est apparu en premier sur HealthCare Innovation.

HealthCare Innovation (HCI) proudly announces the signing of a Memorandum of Understanding (MOU) with the Arab Information and Communication Technologies Organization (AICTO), marking a major milestone in regional digital health collaboration.

This strategic agreement establishes a framework for joint action in Responsible Artificial Intelligence, health data governance, digital infrastructure, and HealthTech regional expansion. It reflects a shared commitment to building sovereign, interoperable, and innovation-driven digital health ecosystems across the Arab region.

We extend our sincere appreciation to H.E. Eng. Mohamed Benamor, Director General of AICTO, for his trust and shared vision.

Why This Partnership Matters

Healthcare systems globally are undergoing accelerated digital transformation. The WHO Global Strategy on Digital Health (2020–2025) emphasizes governance, interoperability, and ethical AI frameworks as pillars of safe and equitable digital health systems. The OECD similarly highlights that data governance and cross-border interoperability are critical for scaling innovation.

The HCI–AICTO MOU directly addresses these priorities within the Arab region.

Partnership Overview

• Signatories: HealthCare Innovation (HCI) and Arab Information and Communication Technologies Organization (AICTO)
• Nature of Agreement: Strategic Memorandum of Understanding
• Core Areas: Responsible AI in Health, Health Data Governance, Digital Infrastructure & Interoperability, Startup Regional Expansion
• Geographical Scope: Arab region and Euro-Med innovation ecosystem

Strategic Impact for Tunisia & the Arab Region

• Strengthening Tunisia’s positioning as a regional HealthTech hub
• Advancing Responsible AI governance in healthcare systems
• Supporting sovereign and secure health data infrastructures
• Facilitating cross-border HealthTech market access
• Encouraging harmonization of digital health standards across the region

Next Steps

The partnership will move toward operationalization through joint working groups, regional expert forums, pilot interoperability initiatives, and structured startup soft-landing mechanisms across Arab markets.

HCI Resources

Accelerating Innovation in HealthTech 
Startup Programs 
Pharma & Medical Device Regulatory Services 
Experts Network 
Community Overview 

External References

WHO — Global Strategy on Digital Health (2020–2025)
OECD — Digital Health Overview
AICTO — Official Website

L’article HCI & AICTO Sign MOU for Responsible Digital Health est apparu en premier sur HealthCare Innovation.

We are proud to announce the signing of a partnership agreement between BiotechPole Sidi Thabet and HealthCare Innovation (HCI), with a clear priority: accelerating Digital Health in Tunisia.

This collaboration aims to strengthen the national innovation ecosystem by building structured digital health and biotech pipelines, connecting startups with healthcare stakeholders, and enhancing joint capacity to respond to national and international funding opportunities.

Why This Partnership Matters

Digital health transformation requires strong coordination between research hubs, innovation clusters, and industry actors. The WHO Global Strategy on Digital Health (2020–2025) emphasizes ecosystem collaboration, governance, and interoperability as foundational pillars for effective health system modernization. The OECD similarly highlights that innovation ecosystems must connect research, startups, and industry to scale impactful solutions.

This partnership aligns with these priorities by creating structured collaboration between Tunisia’s biotech infrastructure and HealthTech innovation ecosystem.

Joint Program Objectives

• Launch a joint Digital Health & biotech project pipeline, including proposal development and coordinated responses to national and international calls.
• Organize co-branded ecosystem events such as workshops, conferences, and seminars connecting startups with healthcare and industry stakeholders.
• Provide joint support for startups and SMEs through advisory services, partnership structuring, and ecosystem access.

Strategic Impact for Tunisia

• Strengthening Tunisia’s Digital Health and biotech project pipeline readiness
• Enhancing startup access to structured advisory and partnership frameworks
• Increasing participation in national and international innovation calls
• Building stronger bridges between research, industry, and entrepreneurship ecosystems
• Positioning Tunisia as a competitive hub for HealthTech and biotech collaboration

Next Steps

Following this agreement, both institutions will begin structuring joint working groups, mapping project opportunities, and launching coordinated ecosystem events to accelerate tangible impact across Digital Health and biotech domains.

HCI Resources

Accelerating Innovation in HealthTech 
Startup Programs
Pharma & Medical Device Regulatory Services 
Experts Network 
Community Overview 

External Citations

WHO — Global Strategy on Digital Health (2020–2025)
OECD — Digital Health Overview

L’article BiotechPole Sidi Thabet & HCI Digital Health Partnership est apparu en premier sur HealthCare Innovation.

HealthCare Innovation is proud to announce the signing of a partnership agreement with GFI Group — bringing together Polytech Sousse and connway academy — to strengthen HealthTech innovation and advanced IT expertise in Tunisia and beyond.

By bridging digital health innovation with cutting-edge IT capabilities, this collaboration reinforces a shared commitment to building scalable, secure, and impactful e-health solutions while positioning Tunisia as a competitive hub for HealthTech development.

Why This Partnership Matters

The evolution of digital health increasingly depends on strong integration between healthcare expertise and advanced information technologies such as Artificial Intelligence, Cybersecurity, and Business Intelligence. The WHO Global Strategy on Digital Health (2020–2025) emphasizes interoperability, data governance, and innovation capacity as pillars of modern health systems. The OECD likewise highlights that digital transformation in healthcare requires robust IT infrastructure and talent development.

This partnership directly addresses these priorities by connecting HealthTech innovation with specialized IT education and applied research capabilities.

Collaboration Objectives

• Accelerate innovation in digital health and e-health solutions through structured joint initiatives.
• Integrate advanced IT expertise in Artificial Intelligence, Cybersecurity, and Business Intelligence into HealthTech projects.
• Support talent development and applied research for national and international innovation initiatives.

Strategic Impact for Tunisia

• Strengthening the integration of IT excellence into HealthTech ecosystems.
• Enhancing cybersecurity and data protection standards within digital health solutions.
• Expanding applied research collaboration between education institutions and innovation clusters.
• Supporting scalable HealthTech solutions ready for regional and international deployment.
• Positioning Tunisia as a competitive and secure hub for digital health innovation.

Next Steps

The partnership will move toward operationalization through joint programs, collaborative workshops, innovation challenges, and coordinated participation in national and international calls for projects. Both institutions aim to translate this strategic alignment into measurable impact across education, technology, and healthcare.

HCI Resources

Accelerating Innovation in HealthTech 
Startup Programs
Pharma & Medical Device Regulatory Services 
Experts Network 
Community Overview 

External Citations

WHO — Global Strategy on Digital Health (2020–2025)
OECD — Digital Health Overview

L’article HealthCare Innovation & GFI Group Sign Strategic HealthTech Partnership est apparu en premier sur HealthCare Innovation.

HealthCare Innovation is proud to announce the signature of a strategic partnership agreement with DataXion, marking an important step in strengthening secure and compliant health data infrastructure for the HealthTech ecosystem.

As part of this collaboration, HealthCare Innovation organized an immersive visit for our community of HealthTech startups and project leaders at DataXion’s data center, reinforcing practical understanding of secure hosting environments and regulatory compliance requirements.

Immersive Visit & Technical Program

• A guided tour of DataXion’s data center infrastructure
• A dedicated workshop on health data hosting, compliance, and data sovereignty
• Open discussions and Q&A sessions addressing real-world data challenges faced by HealthTech entrepreneurs

Shared Strategic Objective

The partnership aims to enable HealthTech startups to access secure, compliant, and sovereign cloud and data center environments from the earliest stages of development, fully aligned with health data regulatory requirements.

By embedding compliance and cybersecurity foundations early in the innovation lifecycle, the collaboration contributes to building credible, investment-ready, and scalable digital health solutions.

Why Secure Health Data Infrastructure Matters

The WHO Global Strategy on Digital Health (2020–2025) emphasizes strong governance, cybersecurity, and data protection as essential pillars for trusted digital health systems. The OECD likewise highlights that secure data infrastructure and regulatory compliance are prerequisites for scaling AI-driven and digital health solutions.

Through this partnership, HealthCare Innovation and DataXion are reinforcing Tunisia’s readiness to support market-ready HealthTech solutions capable of scaling locally and internationally.

Strategic Impact for Tunisia

• Strengthening secure and sovereign health data hosting capacity
• Enhancing compliance and regulatory readiness for HealthTech startups
• Improving cybersecurity awareness within the digital health ecosystem
• Supporting scalable cloud and AI-driven healthcare innovation
• Positioning Tunisia as a trusted hub for secure HealthTech infrastructure

HCI Resources

Accelerating Innovation in HealthTech 
Startup Programs
Pharma & Medical Device Regulatory Services 
Experts Network 
Community Overview 

External Citations

WHO — Global Strategy on Digital Health (2020–2025)
OECD — Digital Health Overview: 

L’article HealthCare Innovation & DataXion Sign Strategic Health Data Partnership est apparu en premier sur HealthCare Innovation.